P. Lipponen
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 17
- Breast Cancer Treatment Studies 14
- Cancer, Lipids, and Metabolism 11
- Oncology 50
- Cancer-related Molecular Pathways 13
- Cancer Immunotherapy and Biomarkers 13
- Co-authors
- Matti J. Eskelinen (69 shared papers)Sirpa H. Aaltomaa (43 shared papers)Kari Juhani Syrjänen (43 shared papers)Veli‐Matti Kosma (18 shared papers)Matti Eskelinen (13 shared papers)S. Vesalainen (10 shared papers)Martti T. Talja (9 shared papers)Veli‐Matti Kosma (5 shared papers)
In The Last Decade
P. Lipponen
148 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 120
- Oncology 2.0k
- Cancer Research 1.1k
- Surgery 1.4k
- Pulmonary and Respiratory Medicine 970
- Immunology 549
Countries citing papers authored by P. Lipponen
This map shows the geographic impact of P. Lipponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lipponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lipponen more than expected).
Fields of papers citing papers by P. Lipponen
This network shows the impact of papers produced by P. Lipponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lipponen. The network helps show where P. Lipponen may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Lipponen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 342 | |
| 2 | 1992 | 245 | |
| 3 | 1993 | 221 | |
| 4 | 1994 | 218 | |
| 5 | 1994 | 209 | |
| 6 | 1994 | 177 | |
| 7 | 2001 | 150 | |
| 8 | 1999 | 148 | |
| 9 | 1995 | 142 | |
| 10 | 1994 | 127 | |
| 11 | 1994 | 119 | |
| 12 | Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy. | 2006 | 111 |
| 13 | 1993 | 102 | |
| 14 | 1999 | 102 | |
| 15 | 1993 | 90 | |
| 16 | 1995 | 82 | |
| 17 | 1999 | 82 | |
| 18 | 1992 | 78 | |
| 19 | 1998 | 74 | |
| 20 | 1999 | 70 |
About P. Lipponen
P. Lipponen is a scholar working on Cancer Research, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 148 papers that have together received 5.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (51 papers), Urinary and Genital Oncology Studies (25 papers), Cancer Genomics and Diagnostics (17 papers), Breast Cancer Treatment Studies (14 papers), Cancer-related Molecular Pathways (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Prostate Cancer Treatment and Research (13 papers) and Cancer, Lipids, and Metabolism (11 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (1.1k citations), Surgery (1.4k citations), Pulmonary and Respiratory Medicine (970 citations) and Immunology (549 citations). P. Lipponen has collaborated with scholars based in Finland, Italy and Slovenia. Frequent co-authors include Matti J. Eskelinen, Sirpa H. Aaltomaa, Kari Juhani Syrjänen, Veli‐Matti Kosma, Matti Eskelinen, S. Vesalainen, Martti T. Talja, Veli‐Matti Kosma, Martti Ala‐Opas and E. M. ALHAVA. Their work appears in journals such as European Urology, The Journal of Pathology, European Journal of Cancer, Journal of Cancer Research and Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.